Evidence map›Paper›PMID 34722493›Full record

ArticleOcular oncology and pathology2021

Uveal Melanoma: Refusal of Treatment.

Randy Christopher Bowen, Soto Hansell, Vishal Raval, Jacquelyn M Davanzo, Arun D Singh

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Ocular oncology and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Randy Christopher BowenCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Soto HansellCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Vishal RavalCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Jacquelyn M DavanzoCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Arun D SinghCole Eye Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aimed to explore factors for refusing treatment in patients diagnosed with uveal melanoma and their subsequent clinical course.

methodsThis study included patients with uveal melanoma who refused standard of care treatment. Patient-reported reasons and pre-existing mental health diagnoses were assessed. The sociodemographic profile was compared with the controls. Ocular survival, metastasis-free survival (MFS), and overall survival (OS) were calculated.

resultsNine patients with uveal melanoma declined ocular treatment (plaque brachytherapy,

conclusionsRefusal of initial recommended treatment is associated with poor ocular survival. The small sample size did not allow for an evaluation of the impact on survival.

Indexed as

Choroidal melanomaRefusal of careSociodemographic profileUveal melanoma

Identifiers

PMID34722493
PMCPMC8531830

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.